4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
NeuroSense Therapeutics Ltd. (NRSN) operates in the Biotechnology industry and is headquartered in Herzliya, Israel with about 17 employees. Its market capitalization is roughly $25 million. In the fiscal year ended 2025-12-31, NRSN reported $0M in revenue and ($11M) in net income.
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($11M) | ($10M) | ($12M) | ($11M) | — |
| Net Income | ($11M) | ($10M) | ($10M) | ($10M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2024-12-31 |
|---|---|
| Total Revenue | $0M |
| Operating Income (EBIT) | ($2M) |
| Net Income | ($2M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1M | $5M | $3M | $8M | — |
| Total Liabilities | $3M | $2M | $5M | $2M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NRSN viewer.
About TickerBase · Data methodology & sources